Bioposide 100mg Injection (Etoposide): Comprehensive Global Procurement & Export Guide
Are you searching for a reliable, bulk-scale international distributor of Bioposide 100mg Injection? PRIMECARE IMPEX is an industry-leading pharmaceutical exporter from India, specializing in the end-to-end supply chain management of high-demand oncology therapeutics. We offer optimized, secure, and compliant logistics networks catering directly to medical centers, wholesalers, and institutional buyers in New York (USA), Bristol (UK), Sydney (Australia), and Riyadh (Saudi Arabia).
Product Overview: Bioposide 100mg Injection
Manufactured by Zydus Lifesciences Ltd., Bioposide 100mg contains Etoposide (100mg/5mL).
Primary Clinical Indications
Testicular Cancer: Used primarily in combination therapy for refractory or advanced testicular malignancies.
Small Cell Lung Cancer (SCLC): A first-line therapeutic standard for aggressive pulmonary tumors.
Acute Myeloid Leukemia (AML): Integrated into specialized blood cancer induction and consolidation protocols.
Lymphomas: Effective in managing both Hodgkin’s and non-Hodgkin’s lymphoma variants.
Ovarian Cancer: Indicated for advanced or recurrent epithelial ovarian malignancies.
Detailed Technical Product Information
1. Mechanism of Action
Bioposide 100mg operates primarily as a cell-cycle-dependent cytotoxic agent. The active drug, Etoposide, targets and inhibits the crucial cellular enzyme Topoisomerase II.
By binding to the Topoisomerase II-DNA complex, Etoposide prevents the re-ligation of DNA strands, inducing single- and double-stranded DNA breaks. This catastrophic structural damage disrupts DNA synthesis and halts the cell cycle at the G2/M phase, triggering apoptosis (programmed cell death) selectively in rapidly proliferating cancer cells.
2. Technical Storage and Fluid Handling
Unopened Vials: Must be stored at controlled room temperature, ideally below 25°C (77°F).
Keep the vials securely enclosed within the original outer commercial carton to shield the formulation from direct light degradation. Reconstitution and Infusion: Diluted solutions must be monitored carefully. If mixed to concentrations higher than recommended, precipitation can occur. Use only clear, particle-free solutions immediately after dilution.
Hazardous Drug Protocol: Because Etoposide is a known human carcinogen, all healthcare personnel must strictly follow standard cytotoxic safety guidelines during preparation, using protective equipment and minimizing aerosolization risks.
3. Secondary Effects & Clinical Countermeasures
While essential for cancer management, Bioposide 100mg requires stringent hematologic monitoring due to its adverse profile:
Myelosuppression: This is the dose-limiting toxicity. Patients frequently experience leukopenia, neutropenia, and thrombocytopenia, typically reaching a nadir 7 to 14 days post-infusion.
Gastrointestinal Distress: Nausea, vomiting, diarrhea, loss of appetite, and mucosal mouth ulcers are common but manageable via targeted antiemetics.
Cardiovascular Caution: Rapid intravenous administration can induce acute, severe hypotension.
The infusion must be administered slowly over a minimum period of 30 to 60 minutes. Alopecia: Reversible, complete hair loss is frequently reported by patients undergoing treatment.
4. Commercial Advantages of Bioposide 100mg
Proven Global Efficacy: Decades of clinical success make Zydus's Bioposide an essential, irreplaceable asset in international hematology and oncology protocols.
Flexible Combination Potential: Synergizes exceptionally well with cisplatin, bleomycin, and other core anti-cancer agents to maximize tumor clearance.
Optimized Packaging Standards: The 5mL vial structure enables precise single-dose adaptations, minimizing clinical drug waste during compounding.
5. Strict Export Documentation & Quality Compliance
As a verified exporter from India, PRIMECARE IMPEX backs every cross-border cargo shipment with absolute regulatory transparency:
Authentic Certificate of Analysis (COA) verifying batch potency.
GMP Certified sourcing guarantees from Zydus Lifesciences.
Country of Origin Certification, sanitized packing indices, and fully detailed commercial invoices.
Secured Global Logistics: Ensuring specialized shock-resistant, climate-controlled shipping profiles to protect liquid vials across transit corridors.
B2B Trade Disclaimer: Bioposide 100mg (Etoposide) Injection is a highly hazardous cytostatic prescription medication. It must be prepared, calculated, and administered strictly under the real-time supervision of a certified oncologist within specialized medical centers.
The information organized here serves strictly as a high-level digital reference catalog for internationalwholesale buyers, procurement agents, and distribution managers. It does not replace professional medical advice, patient diagnosis, or direct clinical consultation.
📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India
[GROUP OF PRIME CARE IMPEX PVT. LTD.]
